2017 Subject Index
Abdominal wall elevation............................................. 174
Abdominal wall lifting.................................................. 174
Anti-Müllerian hormone............................................... 148
Antral follicle count...................................................... 148
Appendectomy............................................................. 116
Atypical hyperplasia..................................................... 127
Autoimmune thyroid disease........................................ 85
Bbstetric outcome......................................................... 90
Big gynecologic tumors................................................ 195
Blastocyst transfer........................................................ 133
Boost............................................................................ 67
Borderline tumors......................................................... 195
Breast cancer................................................................ 67
Bupivacaine.................................................................. 26
Celiac disease............................................................... 56
Cervical cancer............................................................. 77
Cervical intraepithelial neoplasia grade I....................... 1
Cesarean delivery......................................................... 26
Chemotherapy.............................................................. 33
Clinical pregnancy rates................................................ 38
Clips............................................................................. 67
Colpotomy.................................................................... 143
Concomitant................................................................. 127
Controlled ovarian stimulation...................................... 148
Culdolaparoscopy......................................................... 143
Cytoreduction............................................................... 33
Da Vinci....................................................................... 96
Depth............................................................................ 185
DHEA.......................................................................... 160
Diacyl glycerol............................................................. 102
Dysplasia...................................................................... 185
Education level................................................................... 72
Elongated...................................................................... 139
Embryo development.................................................... 102
Endometrial cancer....................................................... 110
Endometrial carcinoma................................................. 127
Endometrioid endometrial adenocarcinoma.................. 139
Endometriosis............................................................... 200
Endometrium................................................................ 160
Episiotomy................................................................... 190
Epithelial ovarian cancer............................................... 33,116
Extraperitoneal.............................................................. 77
Family planning method............................................... 72
Fertility-sparing surgery............................................... 43
Financial status.................................................................. 72
Follicle.......................................................................... 167
Fragmented pattern....................................................... 139
Fresh embryo transfer.................................................. 38
Frozen embryo transfer................................................ 38
General surgery............................................................ 200
Geographic miss index................................................. 67
Gluten-free diet............................................................. 56
Group B Streptococcus................................................ 181
Gynecology.................................................................. 200
High-grade squamous intraepithelial lesion.................. 185
Homeobox genes.......................................................... 160
Hormone...................................................................... 210
Human chorionic gonadotropin administration............. 133
Human papilloma virus................................................ 1
Human papilloma virus genotyping.............................. 1
Hypertensive disorders................................................. 20
Hypoactive................................................................... 210
Hyposexuality.............................................................. 210
Hysterectomy............................................................... 62
Iatrogenic...................................................................... 15
Immature teratoma........................................................ 43
In in vitro fertilization................................................... 148
India............................................................................. 181
Individualization........................................................... 148
Infection....................................................................... 181
Infertility....................................................................... 48
Inflammatory markers.................................................. 122
Inositol triphosphate..................................................... 102
Insulin resistance.......................................................... 85
Laparoscopic entry....................................................... 174
Laparoscopy................................................................. 200
Leiomyoma................................................................... 195
Liposomes.................................................................... 102
Loop electrosurgical excision procedures..................... 185
Low-dose corticosteroids............................................. 56
Low-grade squamous intraepithelial lesion................... 1
Low-molecular- weight heparin.................................... 56
Lymph node................................................................. 77
Lymphadenectomy....................................................... 96,127
Lymphovascular space invasion................................... 139
Maternal mortality........................................................ 20
Menopause................................................................... 210
Microcystic................................................................... 139
Midurethral sling.......................................................... 9
Myomectomy............................................................... 62
Myometrial invasion..................................................... 139
Natural endoscopic surgery.......................................... 143
Newborn...................................................................... 181
Nodular goiter.............................................................. 85
Normal tissue index...................................................... 67
Obstructed labor .......................................................... 15
Oocyte.......................................................................... 167
Oocyte activation.......................................................... 102
Ovarian cysts................................................................ 195
Ovarian germ cell tumor............................................... 43
Ovary........................................................................... 167
Overactive bladder........................................................ 9
Ovulation induction...................................................... 48
Perinatal morbidity....................................................... 56
Peritoneal cytology....................................................... 110
Pharmacodynamics....................................................... 48
Pharmacokinetic........................................................... 48
Platelet-to-lymphocyte ratio.......................................... 122
Platinum/taxane............................................................ 33
Polycystic ovary syndrome.......................................... 85
Poor responder............................................................. 160
Postoperative pain........................................................ 143
Pregnancy..................................................................... 56,181
Premenopausal............................................................. 43
Preterm delivery........................................................... 185
Preterm premature rupture of membranes..................... 122
Prevalence.................................................................... 190
Progesterone elevation.................................................. 133
Prolapse repair.............................................................. 9
Radiotherapy................................................................ 67
Reduction..................................................................... 67
Regression.................................................................... 1
Reproductive period..................................................... 72
Risk factors.................................................................. 90,116
Robotics....................................................................... 96
Sacrocolpopexy ........................................................... 9
Serous papillary carcinoma........................................... 33
Serum estradiol............................................................. 38
Serum progesterone...................................................... 38
Single port laparoscopy................................................ 143
Small for gestational age............................................... 90
Surgical staging............................................................ 110
Transitional cell carcinoma........................................... 33
Transplantation............................................................. 167
Transvaginal tape.......................................................... 9
Transversus abdominis plane block.............................. 26
Treatment...................................................................... 43
Tumor grade................................................................. 139
Turkey.......................................................................... 20
Urinary fistula.............................................................. 15
Uterine fibroids............................................................ 62
Uterine sarcoma............................................................ 62
Vaginal deliveries......................................................... 190
Vascular endothelial growth factor............................... 167
Vesicovaginal............................................................... 15
Vulval cancer................................................................ 96
Women......................................................................... 210
Wound block 26